This Article Full Text Full Text (PDF) CME: Take the course for this article: Stroke: November 2007, Volume 38, Number 11 All Versions of this Article: 38/11/3084    most recent STROKEAHA.107.490193v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bardutzky, J. Articles by Schwab, S. Search for Related Content PubMed PubMed Citation Articles by Bardutzky, J. Articles by Schwab, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Stroke Hazardous Substances DB TROMETHAMINE Related Collections Other Stroke Treatment - Medical

(Stroke. 2007;38:3084.)
© 2007 American Heart Association, Inc.

Topical Review

Antiedema Therapy in Ischemic Stroke

From Department of Neurology, University of Erlangen, Germany.

Correspondence to Juergen Bardutzky, Department of Neurology, University of Erlangen, Schwabachanlage 6, Germany 91054. E-mail juergen.bardutzky{at}uk-erlangen.de

Marc Fisher MD Section Editor:

Abstract

Life-threatening, space-occupying brain edema occurs in up to 10% of patients with supratentorial infarcts and is traditionally associated with a high mortality rate of up to 80%. Management of these patients is currently being changed to an earlier and more aggressive treatment regimen. Early surgical decompression has recently been proven effective to reduce mortality and increase the number of patients with a favorable outcome in randomized controlled trials and is now the "antiedema" therapy of first choice for patients with large middle cerebral artery infarction aged 60 years or younger. Several medical treatment strategies have been proposed to control brain edema and reduce intracranial pressure, including different osmotherapeutics, hyperventilation, tromethamine, hypothermia, and barbiturate coma. None of these treatments is supported by level 1 evidence of efficacy in clinical trials, and some of them may even be detrimental. Preliminary results on hypothermia for space-occupying hemispheric infarction are encouraging, but far from definitive.

Key Words: conventional antiedema therapy • edema, brain • hemicraniectomy • hypothermia • ischemia

This article has been cited by other articles:

				M. Austinat, S. Braeuninger, J. B. Pesquero, M. Brede, M. Bader, G. Stoll, T. Renne, and C. Kleinschnitz Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema * Expanded Materials and Methods Stroke, January 1, 2009; 40(1): 285 - 293. [Abstract] [Full Text] [PDF]

				B. P. Meloni, F. L. Mastaglia, and N. W. Knuckey Review: Therapeutic applications of hypothermia in cerebral ischaemia Therapeutic Advances in Neurological Disorders, September 1, 2008; 1(2): 75 - 98. [Abstract] [PDF]